Lataa...
Anti-β(2)M monoclonal antibodies kill myeloma cells via cell- and complement-mediated cytotoxicity
Our previous studies showed that anti-β(2)M monoclonal antibodies (mAbs) at high doses have direct apoptotic effects on myeloma cells, suggesting that anti-β(2)M mAbs might be developed as a novel therapeutic agent. In this study, we investigated the ability of the mAbs at much lower concentrations...
Tallennettuna:
| Julkaisussa: | Int J Cancer |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4230340/ https://ncbi.nlm.nih.gov/pubmed/24474467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.28745 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|